SEC Form 4 · accession 0001193125-26-347275
TREACE MEDICAL CONCEPTS, INC. · TMCI
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Sean F. Scanlan
Officer — Chief Innovation Officer
Period of report
Aug 9, 2026
Accepted (ET)
Aug 12, 2026 · 6:00 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001630627
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F2 | Aug 9, 2026 | F | 9,814 | $0.00 | D | 679,863 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Includes 463,167 restricted stock units.
- F2Reflects the transfer of 15,000 shares of common stock to the reporting person's former spouse pursuant to a domestic relations order.